Not conducted pre-approval; Tg.rasH2 mouse and 2-year rat studies required as PMRs
“No new studies were provided. The Division agreed these studies can be completed as post-marketing requirements (PMRs) given the benefit:risk and unmet medical need.”
Combined fertility/EFD in mouse (SC), no adverse effects; rabbit EFD and PPND deferred to PMRs
“No adverse fertility or embryofetal developmental effects were observed in mouse administered zilganersen subcutaneously at doses of 0, 10, 30, or 60 mg/kg once every 2 weeks.”